About Us

MISSION STATEMENT

Implantcast North America provides high-quality, dynamic technologies to orthopedic surgeons and their patients. The extensive portfolio ranges from minimal bone loss replacement to complex limb salvage for tumor, infection, and other major bone loss conditions.

ABOUT IMPLANTCAST GMBH

Implantcast GmbH is one of the world-wide specialists in its sector with regard to development, design, and production of replacement joints. Its core competence lies in the manufacture of endoprostheses as functional joint replacements, specialized implants for unique conditions, and customized products. Constant investments in the location, highest quality ”Made in Germany” products and technologies, skilled employees and its specialized services are the fundamental pillars of company success.

Cooperation with leading tumor and revision specialty centers in Europe for decades has driven historical proficiency and constant improvement in the area of limb salvage. The successful MUTARS^® system is the most frequently used tumor system in Europe and has been used in the United States since 2013 for specialty cases.

MANAGEMENT

Implantcast North America, LLC, headed by President and CEO Andy Hewes, is a distribution and service partner of world-wide well-known orthopedic solutions company implantcast GmbH, headquartered near Hamburg, Germany. Implantcast has extensive experience in the orthopedic tumor and revision space, having first developed and implanted the BSTR tumor system in 1989. implantcast GmbH also developed core competencies in metal alloy crafting. Jens Saẞ, CEO and Managing Director of implantcast GmbH, took over leadership in 1996 and has grown sales to approach $100M and expanded implantcast products into over 65 countries around the world.

OUR STORY

The first MUTARS (Modular Universal Tumor and Revision System) prosthesis, the proximal femur, was implanted in 1992. Its modular design was developed in co-operation with Univ.-Prof. Dr. W. Winkelmann (em. Director) and Univ.-Prof. Dr. G. Gosheger (Director), from the Department of General Orthopaedics and Orthopaedic Oncology at the University Hospital of Münster, Germany.

• In 1992 the first MUTARS (Modular Universal Tumor and Revision System) prosthesis, the proximal femur, was implanted in 1992. Its modular design was developed in co-operation with Univ.-Prof. Dr. W. Winkelmann and Univ.-Prof. Dr. G. Gosheger from the Department of General Orthopaedics and Orthopaedic Oncology at the University Hospital of Münster, Germany.
• In 1996, Jens Saẞ became the Managing Director of implantcast GmbH and shortly thereafter began a new phase of development and production. Along with extending the tumor and revision product portfolios, he focused on expanding distribution partnerships outside of Germany.
• By 2002, implantcast, in addition to MUTARS, had successfully released multiple primary and revision hip systems, the LUMiC partial pelvic replacement, knee implants, and an elbow replacement. Work was in process on a novel silver coating technology.
• Implantcast received an award from the University of Münster for the cooperation between implantcast and the university in the development of antibacterial silver coating in 2004.
• By 2006, 4,000 MUTARS had been implanted. Full primary through tumor hip, knee, and shoulder portfolios were available and major distribution expansion efforts were underway.
• Implantcast underwent major facility expansion in 2011 to accommodate increasing production demand. Products were sold in over 50 countries at this time.
• Implantcast North America, based in Dallas, TX, took root in 2013.
• 2016: The MUTARS system has been extensively expanded and improved as technological advancements are made, and is now a brand known world-wide, with over 15,000 procedures completed, over 5,000 of which are silver coated. Implantcast employs more than 600 employees and has established over 65 distribution partners in the world.
• 2023: In an effort to strive for continuous improvement, implantcast has launched more than 45 new products since 2001, the latest being EPORE (additive manufacturing technology) and MUTARS MK, further strengthening its extensive bone loss portfolio. The new implantcast 3D-Print Center “From Powder to prosthesis” opened at the West site of the company. implantcast’s distribution network includes international partnerships in 80 countries and has offices in 9 countries.